Salzman, David W.
Nakamura, Kotoka
Nallur, Sunitha
Dookwah, Michelle T.
Metheetrairut, Chanatip
Slack, Frank J.
Weidhaas, Joanne B.
Article History
Received: 15 May 2015
Accepted: 4 February 2016
First Online: 21 March 2016
Competing interests
: F.J.S. is a shareholder of Mirna Therapeutics, which is conducting a clinical trial with miR-34 in liver cancer. The other authors declare no competing financial interest.